Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente se refiere a una composicion farmacéutica líquida de Benznidazol de pH de entre alrededor de 3 y alrededor de 7, que comprende entre alrededor de 5 y alrededor de 10 mg/ml de Benznidazol, uno o más polietilenglicoles de entre 200 y 600 de peso molecular, y uno o más alcoholes de cadena corta farmacéuticamente aceptables. De preferencia, la composicion comprende además una solucion amortiguadora que mantenga el pH de la misma entre alrededor de 3 y alrededor de 7. La composicion puede ser administrada de manera oral o parenteral para el tratamiento de la patología del Mal de Chagas.This refers to a liquid pharmaceutical composition of Benznidazole of pH between about 3 and about 7, comprising between about 5 and about 10 mg / ml of Benznidazole, one or more polyethylene glycols of between 200 and 600 in weight molecular, and one or more pharmaceutically acceptable short chain alcohols. Preferably, the composition further comprises a buffer solution that maintains its pH between about 3 and about 7. The composition can be administered orally or parenterally for the treatment of Chagas disease.
ARP0601049612006-11-132006-11-13
A LIQUID PHARMACEUTICAL COMPOSITION OF BENZNIDAZOL
AR056810A1
(en)
Solid orally disintegrating pharmaceutical composition comprising 20 mg or less of a corticosteroid and a disintegrator; orally disintegrating tablet; and its use in the treatment of an inflammatory condition of the gastrointestinal tract such as inflammation of the esophagus, gloss, epiglottis, tonsils, oropharynx, among others.
Solid pharmaceutical composition for the controlled release of an active active agent in the gastrointestinal tract comprising at least one acidic agent with solubility of less than 0.3 mg / ml in aqueous solution at a ph around the pka of the acidic agent, a hydrophilic polymer , an achiever; Use in cardiovascular disorders.
Pharmaceutical composition for injection that compensates for an aqueous solution of ibuprofen and trometamol, in which the concentration of ibuprofen is between 2 and 6 mg / ml, the concentration of trometamol is between 1.8 and 5.8 mg / ml, and the pH is between 7.0 and 9.5; and its use for the treatment of pain, inflammation or fever.